Logo image
QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination
Journal article   Peer reviewed

QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination

Alexander Mazur, Boris Strasberg, Jairo Kusniec and Samuel Sclarovsky
International journal of cardiology, Vol.52(1), pp.27-29
1995
DOI: 10.1016/0167-5273(95)02435-Y
PMID: 8707432

View Online

Abstract

Trasodone, a second generation antidepressant, has been shown to equal standard tricyclics in clinical efficacy while causing significantly fewer cardiac side effects. Although clinical trials have demonstrated a relatively safe arrhythmogenic profile, trasodone has been implicated in the pathogenesis of ventricular arrhythmias. This report describes a patient in whom the administration of trasodone in addition to previously well-tolerated long-term amiodarone therapy was associated with a marked prolongation of the QT interval and polymorphous ventricular tachycardia. Caution in the concurrent use of trasodone and other medications known to cause QT prolongation and polymorphous ventricular tachycardia is recommended.
Amiodarone QT prolongation Trasodone Polymorphous ventricular tachycardia

Details

Metrics

Logo image